Boston’s Life Science Disruptors 2018

Disruption in biotech can come in different forms, from new technologies that can change the face of medicine, to ideas and initiatives that can challenge the status quo. Boston has both of these in spades, with ambitious biotech startups bent on transforming drug development and industry leaders unafraid to tackle the sector’s toughest issues. But which new companies are forging the most radical paths and are poised to become the biggest disruptors? What is their approach to building a great biotech company, and how are their founders working with leading venture capital investors to pull it off?

Join Xconomy for this annual evening event featuring candid stories from some of New England’s most radical company leaders, founders, and VC backers out to change the game in biotech.

Agenda:

5:00 pm – 6:00 pm Registration & Networking

6:00 pm – 7:45 pm Program

7:45 pm – 8:45 pm Networking Reception

(Click here for more details)

Registration

Early Bird Registration $125 · Regular Registration $175

Startup Special $110 · Student $50

**MASS AWIS members**

Enter Promo Code AWIS

to receive $25 off regular registration

Special Guests:

• David Liu: Co-Founder, Beam Therapeutics; Faculty Vice-Chair, Broad Institute

• John Evans: CEO & Board Member, Beam Therapeutics

• Aviv Regev: Scientific Founder, Celsius Therapeutics; Faculty Chair and Core Member, Broad Institute

• Alexis Borisy: Chair, Celsius Therapeutics; Partner, Third Rock Ventures

• Christoph Lengauer: President, Celsius Therapeutics

• Jennifer Petter: Founder & Chief Scientific Officer,  Arrakis Therapeutics

• Michael Gilman: CEO, Arrakis Therapeutics

(CLICK HERE for more information)